About this trial
The new approach propose in this protocol is based on ultrafast ultrasound and remote palpation of tissue by ultrasonic radiation pressure. Ultrafast ultrasound of biological tissues is based on an innovative ultrasound imaging approach that can image very fast soft tissue events at a rate of several thousands of frames per second and provide quantitative mapping of the elasticity of the tissues. This current project aims is to focus on myocardial rigidity in diastole to better assess the function of the heart failure.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Hospitalization in cardiology services for acute pulmonary edema during heart failure
Natriuretic peptide type B ≥35 pg/ml
Echocardiographic structural alteration
Group "preserved LVEF": Left ventricular Ejection Fraction ≥50%
Disqualifiers
Other associated lung pathology
Other heart disease
Contraindication to MRI or echocardiography gel
Pregnancy
Trial design
Single group
Treatments tested in this trial
SuperSonic image
Diagnostic test3 examen performed assessed to compared evaluation type: Cardiac magnetic resonance imaging, standard ultrasound imaging and ultrafast imaging
Treatment groups
Trial outcomes
Primary outcomes
Myocardial rigidity assessment
Myocardial rigidity measured using this new non-invasive ultrasound imaging technique.
Secondary outcomes
Norms estimation of myocardial rigidity
Estimation of physiological and pathological norms of myocardial rigidity by elastography
Safety of cardiac elastography
patient monitoring (electrocardiogram scope and constants every10 min) for 30 minutes post-examination associated with a "comfort questionnaire" to be completed by the patient after the examination
Sponsors and contacts
Click on the lead sponsor to view all of their trials.